First Time Loading...

Compugen Ltd
NASDAQ:CGEN

Watchlist Manager
Compugen Ltd Logo
Compugen Ltd
NASDAQ:CGEN
Watchlist
Price: 1.96 USD -7.98% Market Closed
Updated: Apr 16, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Compugen Ltd

Revenue
33.5m USD
Cost of Revenue
-2m USD
Gross Profit
31.5m USD
Operating Expenses
-44.4m USD
Operating Income
-13m USD
Other Expenses
-5.8m USD
Net Income
-18.8m USD

Margins Comparison
Compugen Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IL
Compugen Ltd
NASDAQ:CGEN
174.9m USD
94%
-39%
-56%
US
Thermo Fisher Scientific Inc
NYSE:TMO
215.7B USD
40%
17%
14%
US
Danaher Corp
NYSE:DHR
177.2B USD
59%
22%
20%
US
IQVIA Holdings Inc
NYSE:IQV
42B USD
35%
14%
9%
CH
Lonza Group AG
SIX:LONN
38.6B CHF
36%
20%
10%
US
Agilent Technologies Inc
NYSE:A
41.1B USD
51%
19%
18%
KR
Samsung Biologics Co Ltd
KRX:207940
55.8T KRW
49%
30%
23%
US
West Pharmaceutical Services Inc
NYSE:WST
27.8B USD
38%
24%
20%
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD
59%
29%
21%
IE
ICON PLC
NASDAQ:ICLR
24.7B USD
30%
13%
8%
FR
Sartorius Stedim Biotech SA
PAR:DIM
23.5B EUR
44%
17%
11%
Country IL
Market Cap 174.9m USD
Gross Margin
94%
Operating Margin
-39%
Net Margin
-56%
Country US
Market Cap 215.7B USD
Gross Margin
40%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 177.2B USD
Gross Margin
59%
Operating Margin
22%
Net Margin
20%
Country US
Market Cap 42B USD
Gross Margin
35%
Operating Margin
14%
Net Margin
9%
Country CH
Market Cap 38.6B CHF
Gross Margin
36%
Operating Margin
20%
Net Margin
10%
Country US
Market Cap 41.1B USD
Gross Margin
51%
Operating Margin
19%
Net Margin
18%
Country KR
Market Cap 55.8T KRW
Gross Margin
49%
Operating Margin
30%
Net Margin
23%
Country US
Market Cap 27.8B USD
Gross Margin
38%
Operating Margin
24%
Net Margin
20%
Country US
Market Cap 26.8B USD
Gross Margin
59%
Operating Margin
29%
Net Margin
21%
Country IE
Market Cap 24.7B USD
Gross Margin
30%
Operating Margin
13%
Net Margin
8%
Country FR
Market Cap 23.5B EUR
Gross Margin
44%
Operating Margin
17%
Net Margin
11%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Compugen Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IL
Compugen Ltd
NASDAQ:CGEN
174.9m USD
-26%
-17%
-15%
-89%
US
Thermo Fisher Scientific Inc
NYSE:TMO
215.7B USD
13%
6%
9%
8%
US
Danaher Corp
NYSE:DHR
177.2B USD
9%
6%
7%
6%
US
IQVIA Holdings Inc
NYSE:IQV
42B USD
23%
5%
10%
9%
CH
Lonza Group AG
SIX:LONN
38.6B CHF
7%
4%
10%
8%
US
Agilent Technologies Inc
NYSE:A
41.1B USD
21%
11%
14%
14%
KR
Samsung Biologics Co Ltd
KRX:207940
55.8T KRW
9%
5%
9%
6%
US
West Pharmaceutical Services Inc
NYSE:WST
27.8B USD
21%
16%
23%
22%
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD
-1 261%
23%
48%
28%
IE
ICON PLC
NASDAQ:ICLR
24.7B USD
7%
4%
7%
6%
FR
Sartorius Stedim Biotech SA
PAR:DIM
23.5B EUR
12%
5%
9%
6%
Country IL
Market Cap 174.9m USD
ROE
-26%
ROA
-17%
ROCE
-15%
ROIC
-89%
Country US
Market Cap 215.7B USD
ROE
13%
ROA
6%
ROCE
9%
ROIC
8%
Country US
Market Cap 177.2B USD
ROE
9%
ROA
6%
ROCE
7%
ROIC
6%
Country US
Market Cap 42B USD
ROE
23%
ROA
5%
ROCE
10%
ROIC
9%
Country CH
Market Cap 38.6B CHF
ROE
7%
ROA
4%
ROCE
10%
ROIC
8%
Country US
Market Cap 41.1B USD
ROE
21%
ROA
11%
ROCE
14%
ROIC
14%
Country KR
Market Cap 55.8T KRW
ROE
9%
ROA
5%
ROCE
9%
ROIC
6%
Country US
Market Cap 27.8B USD
ROE
21%
ROA
16%
ROCE
23%
ROIC
22%
Country US
Market Cap 26.8B USD
ROE
-1 261%
ROA
23%
ROCE
48%
ROIC
28%
Country IE
Market Cap 24.7B USD
ROE
7%
ROA
4%
ROCE
7%
ROIC
6%
Country FR
Market Cap 23.5B EUR
ROE
12%
ROA
5%
ROCE
9%
ROIC
6%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More